This Webull webinar provides an overview of eXoZymes’ AI-enhanced, cell-free biomanufacturing...

eXoZymes’ May 2026 investor presentation outlines the company’s vision for transforming chemical...

CCO at eXoZymes, Damien Perriman, interviewed at Nasdaq around our NCT project: "We’ve shown that...

Using eXoZymes' tech transfer package, Cayman Chemical advanced the protocol from a one-liter...

One of the biggest challenges of conventional technologies is the long timelines to advance...